Search Results - "Frago Larramona, Santiago"
-
1
Real‐world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The ADA‐SWITCH study
Published in Alimentary pharmacology & therapeutics (01-07-2023)“…Summary Background and Aims Data on the outcomes after switching from adalimumab (ADA) originator to ADA biosimilar are limited. The aim was to compare the…”
Get full text
Journal Article -
2
Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn’s disease
Published in United European gastroenterology journal (01-11-2020)“…Background There is limited evidence on the effectiveness of biological therapy in stricturing complications in patients with Crohn’s disease. Aim The study…”
Get full text
Journal Article -
3
Acute cholangitis secondary to hydatid membranes in the biliary tract
Published in Gastrointestinal endoscopy (01-01-2019)Get full text
Journal Article -
4
Educational nurse-led telephone intervention shortly before colonoscopy as a salvage strategy after previous bowel preparation failure: a multicenter randomized trial
Published in Endoscopy (01-11-2020)“…The most important predictor of unsuccessful bowel preparation is previous failure. For those patients with previous failure, we hypothesized that a nurse-led…”
Get more information
Journal Article -
5
Impact of Biological Agents on Postsurgical Complications in Inflammatory Bowel Disease: A Multicentre Study of Geteccu
Published in Journal of clinical medicine (26-09-2021)“…Background: The impact of biologics on the risk of postoperative complications (PC) in inflammatory bowel disease (IBD) is still an ongoing debate. This lack…”
Get full text
Journal Article